NanoVibronix Statistics
Total Valuation
NanoVibronix has a market cap or net worth of $2.12 million. The enterprise value is -$465,541.
Market Cap | 2.12M |
Enterprise Value | -465,541 |
Important Dates
The next estimated earnings date is Friday, August 9, 2024, before market open.
Earnings Date | Aug 9, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
NanoVibronix has 2.78 million shares outstanding. The number of shares has increased by 51.96% in one year.
Shares Outstanding | 2.78M |
Shares Change (YoY) | +51.96% |
Shares Change (QoQ) | +27.79% |
Owned by Insiders (%) | 0.42% |
Owned by Institutions (%) | 13.06% |
Float | 2.50M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.75 |
Forward PS | n/a |
PB Ratio | 0.61 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.45, with a Debt / Equity ratio of 0.03.
Current Ratio | 2.45 |
Quick Ratio | 1.26 |
Debt / Equity | 0.03 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -13.47 |
Financial Efficiency
Return on equity (ROE) is -96.00% and return on invested capital (ROIC) is -81.60%.
Return on Equity (ROE) | -96.00% |
Return on Assets (ROA) | -53.10% |
Return on Capital (ROIC) | -81.60% |
Revenue Per Employee | $178,125 |
Profits Per Employee | -$200,125 |
Employee Count | 16 |
Asset Turnover | 0.47 |
Inventory Turnover | 0.37 |
Taxes
In the past 12 months, NanoVibronix has paid $34,000 in taxes.
Income Tax | 34,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -76.81% in the last 52 weeks. The beta is 1.54, so NanoVibronix's price volatility has been higher than the market average.
Beta (5Y) | 1.54 |
52-Week Price Change | -76.81% |
50-Day Moving Average | 0.76 |
200-Day Moving Average | 0.94 |
Relative Strength Index (RSI) | 51.74 |
Average Volume (20 Days) | 26,102 |
Short Selling Information
The latest short interest is 23,556, so 0.85% of the outstanding shares have been sold short.
Short Interest | 23,556 |
Short Previous Month | 34,682 |
Short % of Shares Out | 0.85% |
Short % of Float | 0.94% |
Short Ratio (days to cover) | 0.69 |
Income Statement
In the last 12 months, NanoVibronix had revenue of $2.85 million and -$3.20 million in losses. Loss per share was -$1.69.
Revenue | 2.85M |
Gross Profit | 1.97M |
Operating Income | -2.95M |
Pretax Income | -3.17M |
Net Income | -3.20M |
EBITDA | -2.95M |
EBIT | -2.95M |
Loss Per Share | -$1.69 |
Balance Sheet
The company has $2.70 million in cash and $110,000 in debt, giving a net cash position of $2.59 million or $0.93 per share.
Cash & Cash Equivalents | 2.70M |
Total Debt | 110,000 |
Net Cash | 2.59M |
Net Cash Per Share | $0.93 |
Equity (Book Value) | 3.50M |
Book Value Per Share | 1.26 |
Working Capital | 3.52M |
Cash Flow
In the last 12 months, operating cash flow was -$2.98 million and capital expenditures -$1,000, giving a free cash flow of -$2.98 million.
Operating Cash Flow | -2.98M |
Capital Expenditures | -1,000 |
Free Cash Flow | -2.98M |
FCF Per Share | -$1.19 |
Margins
Gross margin is 68.98%, with operating and profit margins of -103.47% and -112.35%.
Gross Margin | 68.98% |
Operating Margin | -103.47% |
Pretax Margin | -111.16% |
Profit Margin | -112.35% |
EBITDA Margin | -103.47% |
EBIT Margin | -103.47% |
FCF Margin | -104.63% |
Dividends & Yields
NanoVibronix does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -51.96% |
Shareholder Yield | -51.96% |
Earnings Yield | -150.72% |
FCF Yield | -140.37% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on February 9, 2023. It was a reverse split with a ratio of 1:20.
Last Split Date | Feb 9, 2023 |
Split Type | Reverse |
Split Ratio | 1:20 |
Scores
NanoVibronix has an Altman Z-Score of -14.93 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -14.93 |
Piotroski F-Score | 4 |